@ARTICLE{
author={Martin Miguel,...,Tomasevic Zorica I,...,(broj koautora 34)},
year={2017},
title={Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial},
journal={LANCET ONCOLOGY},
volume={18},
number={12},
pages={1688-1700},
document_type={Article},
}